Key opinion leaders examine safety concerns and adverse event trends in psoriasis treatments, discussing how these factors influence decisions to discontinue therapy and transition patients to alternative interventions.

Clinicians analyze long-term efficacy data in psoriasis treatments, focusing on how they communicate and contextualize information about treatment duration to their patients.

Physicians examine the enduring effectiveness and key findings from the POETYK PSO-1 clinical trials, evaluating their impact on the evolving landscape of psoriasis treatment options.

An expert dermatologist examines the efficacy and potential of tapinarof cream, a novel non-steroidal topical treatment, in providing long-term relief for patients with plaque psoriasis.

A dermatologist explores strategies for managing adverse events in psoriasis treatment, with a specific focus on considerations and best practices for patients with skin of color.

An expert dermatologist explores personalized psoriasis treatment strategies, emphasizing patient education on realistic treatment response expectations and proper application techniques to enhance therapeutic efficacy.

A board-certified dermatologist examines evidence-based strategies for managing plaque psoriasis, focusing on personalized non-steroidal treatment options to optimize patient outcomes.

Medical experts explore approaches for addressing suboptimal outcomes in systemic psoriasis treatments, including methods to enhance therapeutic efficacy and criteria for transitioning to alternative treatments.

Dermatology experts examine the role of IL-17 inhibitors in psoriasis management, focusing on treatment strategies, swift clinical responses, and their effectiveness across various anatomical sites affected by plaque psoriasis.

Dr. Jonathan Rodrigues highlights challenges in management of patients with chronic spontaneous urticaria and why shared decision-making is critical.

Dr. Jonathan Rodrigues shares insights regarding the assessment of chronic spontaneous urticaria and the impact of delays in diagnosis.

Dr. Jonathan Rodrigues reviews the clinical features of chronic spontaneous urticaria and discusses the evolving understanding of the disease.

Medical professionals discuss ongoing clinical trials and novel medications for the treatment of psoriasis.

Key opinion leaders examine TYK2 inhibition and deucravacitinib, focusing on the mechanism of action, safety profile, and strategies for effective patient-provider communication regarding this treatment approach.

Andrew Alexis, MD, MPH, reviews the case of a 66-year-old woman who presented with depigmented patches and provides clinical insights on barriers typically encountered during the management of this condition.

An expert on vitiligo discusses the case of a 49-year-old woman with a history of vitiligo who presents with depigmented macules on her abdomen, thighs, and forearms that developed over 2 months.